Table 3—

Distribution of demographics, rate of awareness and previous diagnosis of allergic rhinitis, and allergic rhinitis classification, in subjects with clinical diagnosis of allergic rhinitis at step two of the study

BelgiumFranceGermanyItalySpainUKAll countries
Total n10194533710026411
Demographic
 Age#39.0 (36.3–41.7)38.8 (36.0–41.6)38.0 (34.5–41.5)41.5 (38.0–45.0)31.3 (29.1–33.6)42.7 (37.6–47.8)37.4 (36.1–38.7)
 Female49 (48.5; 38.4–58.7)53 (56.4; 45.8–66.6)24 (45.3; 31.6–59.6)21 (56.8; 39.5–72.9)34 (34.0; 24.8–44.2)13 (50.0; 29.9–70.1)194 (47.2; 42.3–52.2)
Previous self-report
 Self-aware of allergic rhinitis66 (65.3; 55.2–74.5)57 (60.6; 50.0–70.6)44 (83.0; 70.2–91.9)31 (83.8; 68.0–93.8)64 (64.0; 53.8–73.4)21 (80.8; 60.6–93.4)283 (68.9; 64.1–73.3)
 Physician-based diagnosis of allergic rhinitis53 (52.5; 42.3–62.5)43 (45.7; 35.4–56.3)35 (66.0; 51.7–78.5)26 (70.3; 53.0–84.1)52 (52.0; 41.8–62.1)15 (57.7; 36.9–76.6)224 (54.5; 49.5–59.4)
Allergic rhinitis classification
 PAR72 (72.0; 62.1–80.5)51 (55.4; 44.7–65.8)10 (19.2; 9.6–32.5)13 (35.1; 20.2–52.5)48 (48.5; 38.3–58.7)15 (57.7; 36.9–76.6)209 (51.5; 46.5–56.4)
 Persistent25 (24.8; 16.7–34.3)27 (28.7; 19.9–39.0)20 (41.7; 27.6–56.8)12 (32.4; 18.0–49.8)21 (21.0; 13.5–30.3)14 (53.8; 33.4–73.4)119 (29.3; 24.9–34.0)
  • Data are presented as n (%; 95% confidence interval) unless otherwise stated. PAR: perennial allergic rhinitis. #: mean; : as defined by Allergic Rhinitis and its Impact on Asthma (ARIA) study